Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.2 (
guanylate cyclase
)
8,497
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Polychlorinated biphenyls (PCBs) are persistent organic pollutants present in human blood and milk. Exposure to PCBs during pregnancy and lactation leads to cognitive impairment in children. Perinatal exposure to PCB 153 or
PCB 126
impairs the glutamate-nitric oxide-cGMP pathway in cerebellum in vivo and learning ability in adult rats. The aims of this work were: (1) to assess whether long-term exposure of primary cultures of cerebellar neurons to PCB 153 or
PCB 126
reproduces the impairment in the function of the glutamate-nitric oxide-cGMP pathway found in rat cerebellum in vivo; (2) to provide some insight on the steps of the pathway affected by these PCBs; (3) to assess whether the mechanisms of interference of the pathway are different for
PCB 126
and PCB 153. Both PCB 153 and
PCB 126
increase basal levels of cGMP by different mechanisms.
PCB 126
increases the amount of soluble
guanylate cyclase
while PCB 153 does not. PCB 153 reduces the amount of calmodulin while
PCB 126
does not. Also both PCBs impair the function of the glutamate-nitric oxide-cGMP pathway by different mechanisms, PCB 153 impairs nitric oxide-induced activation of soluble
guanylate cyclase
and increase in cGMP while
PCB 126
does not.
PCB 126
reduces NMDA-induced increase in calcium while PCB 153 does not. When PCB 153 and
PCB 126
exhibit the same effect,
PCB 126
was more potent than PCB 153, as occurs in vivo.
...
PMID:Polychlorinated biphenyls PCB 153 and PCB 126 impair the glutamate-nitric oxide-cGMP pathway in cerebellar neurons in culture by different mechanisms. 1952 86